JPRN-UMIN000050343招募中Unknown
Efficacy and Safety of sofosbuvir/velpatasvir for HCV infected patients with decompensated LC - Efficacy and Safety of sofosbuvir/velpatasvir
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 patients judged to be inappropriate to participate in the study by the attending physician 2 patients judged to be inappropriate to participate in the study by the primary physician
研究者
相似试验
已完成
不适用
Efficacy and safety of sofosbuvir/belpatasvir combination tablets for patients infected with pan-genotypic hepatitis C virusChronic liver disease infected with HCVJPRN-UMIN000035625Saitama Medical University35
招募中
不适用
Evaluation of the efficacy of sofosbuvir/velpatasvir and ribavirin in Japanese hepatitis C patients who failed direct-acting antiviral agents: a prospective study in real life settings.cirrhotic and non cirrhotic patients with hepatitis C virusJPRN-UMIN000035713Toranomon Hospital150
招募中
2 期
Efficacy and safety of Sofosbuvir in the treatment of SARS-CoV-2: An Open Label phase II TrialSARS-CoV-2 ?associated SARI.SARS-CoV-2U07.1IRCT20200328046882N1Shahid Beheshti University of Medical Sciences60
招募中
2 期
Efficacy & Safety of Sofosbuvir/Daclatasvir treatment in COVID-19: A randomized, controlled studyCOVID-19SARS-nCoV-2 infectionDRKS00022203PHARCO CORPORATE90
Unknown
3 期
Role of anti Hepatitis C drug (Sofosbuvir and Ribavirin)in Liver disease.CTRI/2017/11/010373ATCO PHARMACEUTICALS62